{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:08:24Z","timestamp":1789153704775,"version":"build-2803163510"},"reference-count":41,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"unspecified","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health","award":["Z01 BC 010313"],"award-info":[{"award-number":["Z01 BC 010313"]}]},{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health","award":["Z01 BC 010876"],"award-info":[{"award-number":["Z01 BC 010876"]}]},{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health","award":["Z01 BC 010877"],"award-info":[{"award-number":["Z01 BC 010877"]}]},{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health","award":["Z01 BC 011343"],"award-info":[{"award-number":["Z01 BC 011343"]}]},{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health","award":["ZIA BC 011870"],"award-info":[{"award-number":["ZIA BC 011870"]}]},{"name":"NIH","award":["HHSN261201800001I"],"award-info":[{"award-number":["HHSN261201800001I"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is characterised by significant racial disparities in incidence and outcomes, yet whether these reflect distinct tumour biology or differential distribution of molecular subtypes among immunotherapy patients remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We characterised molecular heterogeneity among 46 patients with HCC of differing background population from the NCI-CLARITY cohort receiving immune checkpoint inhibitor therapy, using transcriptomic and genomic profiling, with validation across multiple independent cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Differential expression analysis comparing African American versus non-African American patients identified 126 genes, of which 55 demonstrated tumour-specific expression across independent validation cohorts with paired tumour-normal samples. Consensus clustering revealed two molecular subtypes with no significant race association, indicating these clusters capture tumour-intrinsic biology rather than ancestry. The genomic landscape showed minimal differences between subtypes. A prognostic signature derived from these expression profiles demonstrated significant risk stratification in the NCI-CLARITY cohort and TCGA-LIHC, but not in Asian cohorts, suggesting population-specific applicability. Immune deconvolution revealed that the two subtypes represent distinct immune microenvironments: one subtype exhibited markedly elevated plasma cell infiltration with strong plasma cell-CD8+T\u2009cell correlation suggesting coordinated adaptive immunity, along with elevated tertiary lymphoid structure signatures. The other subtype showed regulatory T cell-macrophage correlation and enrichment for immune-excluded phenotypes. The immune-enriched subtype trended towards higher immunotherapy response rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Molecular heterogeneity in HCC reveals distinct tumour-immune ecosystems that transcend racial classification. Tumour immune heterogeneity in HCC reflects distinct molecular patterns, with immune hot tumours characterised by elevated tertiary lymphoid structure signatures and enriched plasma cell and CD8+T cells. These patterns may serve as prognostic biomarkers for immunotherapy patient stratification and demonstrate the value of diverse cohort representation in identifying clinically relevant therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/egastro-2026-100423","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:35:21Z","timestamp":1788201321000},"page":"e100423","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma cell-CD8+ T cell co-enrichment distinguishes immunotherapy-responsive hepatocellular carcinoma subtypes"],"prefix":"10.1136","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct04145141","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04145141","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Aryan","family":"Neupane","sequence":"first","affiliation":[{"name":"Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-751X","authenticated-orcid":false,"given":"Anuradha","family":"Budhu","sequence":"additional","affiliation":[{"name":"Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid Rashidi","family":"Mehrabadi","sequence":"additional","affiliation":[{"name":"Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu","family":"He","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Kate","family":"Kelley","sequence":"additional","affiliation":[{"name":"Department of Medicine (Hematology\/Oncology), UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F","family":"Greten","sequence":"additional","affiliation":[{"name":"Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Gastrointestinal Malignancies Section, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026091111201220000_4.3.e100423.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.021"},{"key":"2026091111201220000_4.3.e100423.2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cam4.4530","article-title":"The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"key":"2026091111201220000_4.3.e100423.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.05.003"},{"key":"2026091111201220000_4.3.e100423.4","doi-asserted-by":"publisher","DOI":"10.17998\/jlc.2024.03.13"},{"key":"2026091111201220000_4.3.e100423.5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cgh.2023.08.016","article-title":"Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity","volume":"22","author":"Pinheiro","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091111201220000_4.3.e100423.6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.32394","article-title":"Racial\/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018","volume":"76","author":"Alvarez","year":"2022","journal-title":"Hepatology"},{"key":"2026091111201220000_4.3.e100423.7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24817"},{"key":"2026091111201220000_4.3.e100423.8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/hep4.1863","article-title":"Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma","volume":"6","author":"Wagle","year":"2022","journal-title":"Hepatol Commun"},{"key":"2026091111201220000_4.3.e100423.9","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1088"},{"key":"2026091111201220000_4.3.e100423.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"2026091111201220000_4.3.e100423.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030"},{"key":"2026091111201220000_4.3.e100423.12","doi-asserted-by":"publisher","DOI":"10.1038\/nature16969"},{"key":"2026091111201220000_4.3.e100423.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0"},{"key":"2026091111201220000_4.3.e100423.14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.gastro.2020.09.031","article-title":"Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice","volume":"160","author":"Heinrich","year":"2021","journal-title":"Gastroenterology"},{"key":"2026091111201220000_4.3.e100423.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.007"},{"key":"2026091111201220000_4.3.e100423.16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.21037\/atm-20-5830","article-title":"Regulatory T cell and activated natural killer cell infiltration in hepatocellular carcinoma: immune cell profiling using the CIBERSORT","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026091111201220000_4.3.e100423.17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.21037\/jgo-21-291","article-title":"Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma","volume":"12","author":"Meng","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"2026091111201220000_4.3.e100423.18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2293"},{"key":"2026091111201220000_4.3.e100423.19","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2014.1002353"},{"key":"2026091111201220000_4.3.e100423.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.101052","article-title":"Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy","volume":"4","author":"Budhu","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026091111201220000_4.3.e100423.21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170"},{"key":"2026091111201220000_4.3.e100423.22","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2026091111201220000_4.3.e100423.23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2026091111201220000_4.3.e100423.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1373-2"},{"key":"2026091111201220000_4.3.e100423.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-014-0064-y","article-title":"FLAGS, frequently mutated genes in public exomes","volume":"7","author":"Shyr","year":"2014","journal-title":"BMC Med Genomics"},{"key":"2026091111201220000_4.3.e100423.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8"},{"key":"2026091111201220000_4.3.e100423.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006"},{"key":"2026091111201220000_4.3.e100423.28","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337"},{"key":"2026091111201220000_4.3.e100423.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.046"},{"key":"2026091111201220000_4.3.e100423.30","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0074"},{"key":"2026091111201220000_4.3.e100423.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8"},{"key":"2026091111201220000_4.3.e100423.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8"},{"key":"2026091111201220000_4.3.e100423.33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat Commun"},{"key":"2026091111201220000_4.3.e100423.34","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357127","article-title":"Human mitochondrial ADP\/ATP carrier SLC25A4 operates with a ping-pong kinetic mechanism","volume":"24","author":"Cimadamore-Werthein","year":"2023","journal-title":"EMBO Rep"},{"key":"2026091111201220000_4.3.e100423.35","doi-asserted-by":"crossref","first-page":"117530","DOI":"10.1016\/j.bcp.2025.117530","article-title":"S-adenosylmethionine and nicotinic acid suppress Hepatocellular carcinoma proliferation by targeting SLC25A4","volume":"243","author":"Liu","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"2026091111201220000_4.3.e100423.36","doi-asserted-by":"crossref","first-page":"1410145","DOI":"10.3389\/fgene.2024.1410145","article-title":"Comprehensive transcriptomic analysis identifies SLC25A4 as a key predictor of prognosis in osteosarcoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Genet"},{"key":"2026091111201220000_4.3.e100423.37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2762"},{"key":"2026091111201220000_4.3.e100423.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52153-4"},{"key":"2026091111201220000_4.3.e100423.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01992-w"},{"key":"2026091111201220000_4.3.e100423.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02345-0"},{"key":"2026091111201220000_4.3.e100423.41","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-024-01092-z","article-title":"Establishment and validation of a novel CD8+ T cell-associated prognostic signature for predicting clinical outcomes and immunotherapy response in hepatocellular carcinoma via integrating single-cell RNA-seq and bulk RNA-seq","volume":"15","author":"Qu","year":"2024","journal-title":"Discov Oncol"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2026-100423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:20:22Z","timestamp":1789150822000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2026-100423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/egastro-2026-100423"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2026-100423","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}